DE-RISKING RAS - Developing best practice for RAS bio-filters: regular 'maintenance' dosing vs. seed only dosing
降低 RAS 风险 - 开发 RAS 生物过滤器的最佳实践:定期“维护”剂量与仅种子剂量
基本信息
- 批准号:79932
- 负责人:
- 金额:$ 23.83万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Collaborative R&D
- 财政年份:2020
- 资助国家:英国
- 起止时间:2020 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Covid pandemic has shone a light on the need for shorter food supply chains. Currently 53% of food consumed in the UK is produced here, but we are a net importer of seafood. However, with marine fish stocks currently over fished, sustainable growth in UK seafood production as a key part of any Green Recovery will have to come from aquaculture.Recirculating Aquaculture Systems (RAS) are an on-land, tank-based aquaculture system, where water is reused having been put through water remediation systems including bio-filters.RAS are being developed as a potential solution to the issues posed by conventional aquaculture: environmental degradation, the risk of disease or parasites (sea-lice in Atlantic Salmon, for instance), and locations far from final markets leading to high transport costs and emissions.With closed systems and controlled conditions, RAS can solve these problems and provide a more sustainable source of seafood for UK consumers.However, to achieve this, RAS need to overcome key challenges. Foremost among these is the risk of Hydrogen Sulphide (H2S) - a potent toxin in RAS systems. The threat of toxin spikes and so the loss of expensive stock has limited the growth of RAS; conversely, a proven method for solving this problem would help the expansion of this sustainable alternative to conventional aquaculture.The dominant current approach by RAS operators is to 'seed' a bio-filter with bacteria when they start a system, in the expectation that the bacteria that develop with help to control toxins produced in the system, such as ammonia or nitrite. This 'seed and step back' approach can lead to sub-optimal combinations of bacteria species developing, with subsequent spikes in toxins. For instance, when sulphate reducing bacteria (e.g. _Vibrio sp._) are allowed to accumulate in the bio-filters of RAS, they will produce H2S.This project aims to prove the validity of an innovative new approach - 'maintenance dosing'. We aim to prove that the addition of regular applications of specifically chosen bacteria to a RAS bio-filter provides the following key benefits:* more predictable and controlled micro-biome when compared to only applying a starting application;* prevents the proliferation of _Vibrio sp._, therefore reducing the risk of H2S;* prevents the presence of Geosmin and MIB (common contaminants in seafood, resulting in 'off-flavour' taste).'Maintenance dosing' is not common practice in RAS facilities either in the UK or Worldwide. Proof that this innovative approach had the material benefits outlined above would help it become 'standard practice' in the industry, and so facilitate the expansion of sustainable RAS as an alternative to conventional aquaculture.Great British Prawns (GBP) and Nova Q have pioneered this 'maintenance dosing' approach, with successful results achieved in GBP's commercial prawn farm. However, no publicly available, replicated trials have been conducted to provide the data to support these results. This project aims to fill that gap. Great British Aquatech (GBP's R&D subsidiary) and Nova Q have partnered with Scotland's premier independent marine science organisation - the Scottish Association for Marine Science (SAMS) - to conduct this project.
新型冠状病毒肺炎(COVID)大流行突显了缩短食品供应链的必要性。目前,英国消费的食品中有53%是在这里生产的,但我们是海鲜的净进口国。然而,随着海洋鱼类资源目前过度捕捞,英国海产品生产的可持续增长作为任何绿色复苏的关键部分将不得不来自水产养殖。再循环水产养殖系统(RAS)是一种陆地,基于水箱的水产养殖系统,其中水通过包括生物过滤器在内的水修复系统进行再利用。RAS正在开发,作为传统水产养殖所带来问题的潜在解决方案:环境恶化、疾病或寄生虫风险(例如大西洋鲑鱼中的海虱)以及远离最终市场导致高运输成本和排放的地点。凭借封闭的系统和受控的条件,RAS可以解决这些问题,并为英国消费者提供更可持续的海产品来源。然而,要实现这一目标,RAS需要克服关键挑战。其中最重要的是硫化氢(H2S)的风险-RAS系统中的一种强效毒素。毒素激增的威胁以及昂贵库存的损失限制了RAS的增长;相反,解决这个问题的成熟方法将有助于扩大这种传统水产养殖的可持续替代方案。RAS操作员当前的主要方法是在启动系统时在生物过滤器中“接种”细菌,在期望的细菌,发展与帮助控制毒素产生的系统中,如氨或亚硝酸盐。这种“播种和后退”的方法可能导致细菌物种的次优组合发展,随后毒素激增。例如,当硫酸盐还原菌(例如_弧菌属_)本项目旨在证明一种创新的新方法--“维持投加”的有效性。我们的目标是证明,向RAS生物过滤器中添加特定选择的细菌的定期应用提供了以下关键益处:* 与仅应用起始应用相比,更可预测和受控的微生物组;* 防止_弧菌_的增殖,因此降低了H2S的风险;* 防止土臭素和MIB的存在(海鲜中常见的污染物,导致“异味”的味道)。“维持给药”在英国或全球RAS机构中并不常见。证明这种创新方法具有上述物质效益将有助于它成为行业的“标准做法”,从而促进可持续RAS作为传统水产养殖的替代品的推广。大不列颠对虾(GBP)和Nova Q率先采用了这种“维持剂量”方法,并在GBP的商业对虾养殖场取得了成功。然而,尚未进行公开的重复试验来提供支持这些结果的数据。该项目旨在填补这一空白。Great British Aquatech(GBP的研发子公司)和Nova Q与苏格兰首屈一指的独立海洋科学组织--苏格兰海洋科学协会(SAMS)合作开展了这一项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
- 批准号:
2879865 - 财政年份:2027
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
相似海外基金
De-risking activities for the validation of Ecosaf technology for new biobased surfactants for detergent applications
用于验证用于清洁剂应用的新型生物基表面活性剂的 Ecosaf 技术的去风险活动
- 批准号:
10063556 - 财政年份:2023
- 资助金额:
$ 23.83万 - 项目类别:
Collaborative R&D
PAS GRAS: DE-RISKING METABOLIC, ENVIRONMENTAL AND BEHAVIORAL DETERMINANTS OF OBESITY IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS
PAS GRAS:降低儿童、青少年和年轻人肥胖的代谢、环境和行为决定因素的风险
- 批准号:
10078402 - 财政年份:2023
- 资助金额:
$ 23.83万 - 项目类别:
EU-Funded
De-risking multi terminal control for multi-vendor HVDC grid
消除多供应商 HVDC 电网的多终端控制风险
- 批准号:
2879082 - 财政年份:2022
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
HausBots: De-risking the inspection of industrial storage tanks, via a cost efficient, wall climbing, ultrasonic probe robot that generates 3D visual representations of hazardous industrial confined spaces
HausBots:通过具有成本效益的爬壁超声波探头机器人,生成危险工业密闭空间的 3D 视觉表示,降低工业储罐检查的风险
- 批准号:
10032554 - 财政年份:2022
- 资助金额:
$ 23.83万 - 项目类别:
Collaborative R&D
De-risking multi terminal control for multi-vendor HVDC grid
消除多供应商 HVDC 电网的多终端控制风险
- 批准号:
2879473 - 财政年份:2022
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
De-risking new surfactant and polymer classes in personal care formulations
降低个人护理配方中新型表面活性剂和聚合物类别的风险
- 批准号:
LP180101291 - 财政年份:2020
- 资助金额:
$ 23.83万 - 项目类别:
Linkage Projects
De-risking dentistry: Quantifying aerosols associated with routine dentistry to inform mitigation technology and operating practices
降低牙科风险:量化与常规牙科相关的气溶胶,为缓解技术和操作实践提供信息
- 批准号:
EP/V038141/1 - 财政年份:2020
- 资助金额:
$ 23.83万 - 项目类别:
Research Grant
Microbial genomics for de-risking offshore oil and gas exploration in Nova Scotia
用于降低新斯科舍省海上石油和天然气勘探风险的微生物基因组学
- 批准号:
518052-2017 - 财政年份:2017
- 资助金额:
$ 23.83万 - 项目类别:
Connect Grants Level 3
De-risking PWS drug development through preclinical screening
通过临床前筛选降低 PWS 药物开发风险
- 批准号:
1976190 - 财政年份:2017
- 资助金额:
$ 23.83万 - 项目类别:
Studentship
De-risking PWS drug development through preclinical screening
通过临床前筛选降低 PWS 药物开发风险
- 批准号:
1976193 - 财政年份:2017
- 资助金额:
$ 23.83万 - 项目类别:
Studentship